the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Hamas chief Ismail Haniyeh killed in Iran, Hamas says in statement

CAIRO: Hamas leader Ismail Haniyeh was assassinated in the early hours of the morning in Iran, the Palestinian militant group Hamas said on Wednesday, describing the strike as a “severe escalation” that would not achieve its goals.

Iran’s Revolutionary Guards confirmed the death of Haniyeh, hours after he attended a swearing in ceremony for the country’s new president, and said it was investigating.

There was no immediate comment from Israeli authorities.

The White House did not immediately respond to a request for comment on Haniyeh.

The news, which came less than 24 hours after Israel claimed to have killed the Hezbollah commander it said was behind a deadly strike in the Israeli-occupied Golan Heights, appears to set back chances of any imminent ceasefire agreement in Gaza.

“This assassination by the Israeli occupation of Brother Haniyeh is a grave escalation that aims to break the will of Hamas,“ senior Hamas official Sami Abu Zuhri told Reuters.

He said Hamas would continue the path it was following, adding: “We are confident of victory.”

Haniyeh, normally based in Qatar, has been the face of the Palestinian group’s international diplomacy as the war set off by the Hamas-led attack on Israel on Oct. 7 has raged in Gaza, where three of his sons were killed in an Israeli airstrike.

Appointed to the Hamas top job in 2017, Haniyeh has moved between Turkey and Qatar’s capital Doha, escaping the travel curbs of the blockaded Gaza Strip and enabling him to act as a negotiator in ceasefire talks or to talk to Hamas’ ally Iran.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings